https://doi.org/10.1039/9781788012898
Print publication date
15 Jul 2019
Copyright year
2019
Print ISBN
978-1-78801-077-1
PDF eISBN
978-1-78801-289-8
ePub eISBN
978-1-78801-845-6
Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin (Mylotarg™) and moxetumomab pasudotox-tdfk (Lumoxiti®)] and over 70 others are in various stages of clinical development, with impressive interim results being reported for many. The technology is based on the concept of delivering a cytotoxic payload selectively to cancer cells by attaching it to an antibody targeted to antigens on the cell surfaces. This approach has several advantages including the ability to select patients as likely responders based on the presence of antigen on the surface of their cancer cells and a wider therapeutic index, given that ADC targeting enables a more efficient delivery of cytotoxic agents to cancer cells than can be achieved by conventional chemotherapy, thus minimising systemic toxicity. Although there are many examples of antibodies that have been developed for this purpose, along with numerous linker technologies used to attach the cytotoxic agent to the antibody, there is presently a relatively small number of payload molecules in clinical use. The purpose of this book is to describe the variety of payloads used to date, along with a discussion of their advantages and disadvantages and to provide information on novel payloads at the research stage that may be used clinically in the future.About this book
1、本站所有分享材料(数据、资料)均为网友上传,如有侵犯您的任何权利,请您第一时间通过微信(lib99net)、QQ(24661067)、电话(17898078618)联系本站,本站将在24小时内回复您的诉求!谢谢!
2、本站所有商品,除特殊说明外,均为(电子版)Ebook,请购买分享内容前请务必注意。特殊商品有说明实物的,按照说明为准。
1、自动:在上方保障服务中标有自动发货的宝贝,拍下后,将会自动收到来自卖家的宝贝获取(下载)链接;
2、手动:未标有自动发货的的宝贝,拍下后,卖家会收到邮件、短信提醒,也可通过QQ或订单中的电话联系对方。
1、描述:书籍描述(含标题)与实际不一致的(例:描述PDF,实际为epub、缺页少页、版本不符等);
2、链接:部分图书会给出链接,直接链接到官网或者其他站点,以便于提示,如与给出不符等;
3、发货:手动发货书籍,在卖家未发货前,已申请退款的;
4、其他:如质量方面的硬性常规问题等。
注:经核实符合上述任一,均支持退款,但卖家予以积极解决问题则除外。交易中的商品,卖家无法对描述进行修改!
1、在未购买下前,双方在QQ上所商定的内容,亦可成为纠纷评判依据(商定与描述冲突时,商定为准);
2、在宝贝同时有网站演示与图片演示,且站演与图演不一致时,默认按图演作为纠纷评判依据(特别声明或有商定除外);
3、在没有"无任何正当退款依据"的前提下,写有"一旦售出,概不支持退款"等类似的声明,视为无效声明;
4、虽然交易产生纠纷的几率很小,但请尽量保留如聊天记录这样的重要信息,以防产生纠纷时便于网站工作人员介入快速处理。